Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Kedudukan dalam Saham #13761
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Harga Saham
$0.85814713
Disegerakkan terakhir: 2025-05-14
Modal Pasaran
$463.40M
Perubahan (1 hari)
-2.52%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Alliance Pharma plc (APH)

Kategori

Hasil untuk Alliance Pharma plc (APH)
Hasil pada Dec 2024 TTM: $224.41M
Menurut laporan kewangan terkini daripada Alliance Pharma plc, hasil semasa syarikat (TTM) ialah $224.41M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $230.01M peningkatan berbanding hasil pada tahun 2022 iaitu $202.54M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Alliance Pharma plc dari 2001 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $224.41M 0.00%
2024 $224.41M -2.43%
2023 $230.01M 13.56%
2022 $202.54M -8.21%
2021 $220.65M 24.34%
2020 $177.46M -1.34%
2019 $179.87M 19.46%
2018 $150.56M 7.84%
2017 $139.62M 16.04%
2016 $120.32M 68.90%
2015 $71.24M 5.03%
2014 $67.83M -10.01%
2013 $75.38M 3.50%
2012 $72.83M 2.12%
2011 $71.32M -8.14%
2010 $77.64M 53.57%
2009 $50.56M 59.16%
2008 $31.76M -12.52%
2007 $36.31M 7.34%
2006 $33.83M 60.14%
2005 $21.13M 9.03%
2004 $19.38M 44.44%
2002 $13.42M 51.66%
2001 $8.85M 0.00%
Hasil untuk syarikat atau pesaing serupa